Piramal Pharma Solutions Launches $90M Payload-Linker Suite

Piramal Pharma Solutions unveiled a state-of-the-art payload-linker development and manufacturing suite at its Riverview, Michigan facility.
The suite is part of a broader $90 million U.S. manufacturing expansion that also adds technology to the Lexington, Kentucky sterile injectables plant.
The new capabilities aim to accelerate development of antibody-drug conjugates and other bioconjugates, enhancing PPS’s ADCelerate™ platform and supply-chain security.
CEO Peter DeYoung highlighted the suite’s advanced containment, automation and analytical technologies that enable commercial-scale payload-linker production in the U.S.